Dr. Huhn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10578 Science Center Dr
San Diego, CA 92121
Education & Training
University of MarylandResidency, Neurological Surgery, 1988 - 1993
University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 1987 - 1988
University of Arizona College of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1993 - 2025- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Fellow American Academy of Pediatrics
- Fellow (FACS) American College of Surgeons
- Fellow (FAANS) American Association of Neurological Surgeons
Clinical Trials
- Study of Human Central Nervous System (CNS) Stem Cells Transplantation in Pelizaeus-Merzbacher Disease (PMD) Subjects Start of enrollment: 2009 Nov 01
- Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury Start of enrollment: 2011 Mar 01
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers Start of enrollment: 2018 Mar 30
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsClinical translation of human neural stem cellsAnn Tsukamoto, Nobuko Uchida, Alexandra Capela, Thorsten Gorba, Stephen L. Huhn
Stem Cell Research & Therapy. 2013-08-29 - 98 citationsTransplantation of human central nervous system stem cells – neuroprotection in retinal degenerationTrevor J. McGill, Benjamin Cottam, Bin Lu, Shaomei Wang, S.V. Girman
The European Journal of Neuroscience. 2012-02-01 - 90 citationsCentral nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosisNathan R. Selden, Amira Al-Uzri, Stephen L. Huhn, Thomas K. Koch, Darryn M. Sikora
Journal of Neurosurgery. Pediatrics. 2013-05-31
Press Mentions
Pipeline Therapeutics Receives IND Clearance from FDA to Initiate Phase 1b/2a Study of PIPE-307 in Patients with Relapsing-Remitting Multiple SclerosisMarch 28th, 2022- Pipeline Therapeutics Reports Positive Phase 1 Clinical Results for PIPE-307, a Neuroregenerative Therapeutic for the Treatment of Multiple SclerosisMarch 10th, 2022
- Pipeline Testing PIPE-307 Remyelinating Compound in Healthy VolunteersMarch 9th, 2021
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
